Dr. Johnson will help accelerate the Institute?s mission to treat diabetes using transplantation of macroencapsulated cells without the need for immunosuppression.

After collapsing at a Nov. 19 game, Tucson Roadrunners hockey team captain Craig Cunningham is recovering from cardiac arrest at Banner ? University Medical Center Tucson

University of Arizona President Ann Weaver Hart has named Dr. Leigh Neumayer as interim senior vice president for health sciences. Her appointment will be effective Jan. 1, 2017, following Dr. Joe G.N. "Skip" Garcia's decision to resign his administrative role and step back to faculty.

Get out and play is a call often heard to increase physical activity and optimize health, but in one the first articles published in a peer-reviewed medical journal, UA Health Sciences researchers discuss how augmented reality games can lead to acute treatment in a trauma center.

Using 3-D models for surgery planning before complex procedures and as a potential means to replicate surgical tools in low-resource areas, Dr. David Armstrong and his lab share with The Lancet, a prestigious UK medical journal, their vision of 3-D printing technology in medicine.

Cancers with a particularly poor prognosis pose a major challenge to health care in the 21st century. New research shows that a highly personalized, patient-directed approach is necessary to improve treatment outcomes.

Dr. John Hurlbert will join the University of Arizona Division of Neurosurgery on August 15, 2016, in the role of Co-Director of the UA Spine Program. His focus will be program-building, residency and spine fellowship training, and clinical and translational research.

Honoring the best of the best, the University of Arizona Health Sciences 2016 Awards for Excellence recognize the service and achievement of appointed personnel and staff.

Diabetic foot ulcers are more costly to treat than the five leading cancers. In response, UAHS physician-scientists David Armstrong, DPM, MD, PhD, and Marvin Slepian, MD, have begun discussions with Cuban researchers to steward the FDA approval for a diabetic foot ulcer healing drug for use in the United States.

Funds will support research at the UA Steele Center that is examining novel immunotherapy strategies against pediatric cancer.